MAPS speaks with Tim Mikhelashvili, PharmD, CEO & Co-Founder, Amedea Pharma, Inc. and Riaz Abbas, Learning and Performance Lead, JAPAC Medical, Amgen about innovative approaches to Medical Affairs External Education.
In this interview recorded at MAPS 2022 Global with Monica de Abadal, SVP, Head North America Medical Affairs, Ipsen, we discuss how Medical Affairs benefits patients and society.
This podcast, recorded at the MAPS 2022 Global Annual Meeting, addresses the unique position of Medical Affairs in the rare disease space & how our work in this area is essential for patient benefit.
Medical technologies require equipping health care providers with the theoretical knowledge of best and safest use and also ensuring users’ practical competence. This article by the MAPS MedTech and External Education FAWGs overviews these best practices.
Charlotte Kremer (former Astellas) speaks with Danie du Plessis (Kyowa Kirin) and Bjorn Oddens (Merck) about whether Medical Affairs is truly the third strategic pillar.
In this white paper, MedComms, Field Medical and Insights Focus Area Working Groups (FAWGs) demonstrate the value of and elucidate best practices for an insights-driven collaborative approach to creating an iMC S/P.
MAPS is honored to announce the appointment of William (Bill) Sigmund, MD, MHS, EVP and Chief Medical Officer at Becton Dickinson, to the MAPS Board of Directors.
This white paper provides Medical Affairs professionals with the background and history of Real-World Evidence, and its applications in the biopharma industry to benefit patients.
How do leaders make their way to Medical Safety & Pharmacovigilance? The routes are diverse but one constant remains true: They are extremely committed to being an independent voice that amplifies their organization’s commitment to Patient Centricity.
Digitalization offers Medical Affairs teams the opportunity to rethink strategy and actions across the lifecycle of traditional and nontraditional products.